ADIL vs TDG · $6.0M cap vs P/E 41, rev $8.83B
Adial Pharmaceuticals Inc (ADIL) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
ADIL does not have a complete income-statement cache yet.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ADIL currently screens at market cap $6.0M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ADIL and TDG stock pages for the full models.
Not investment advice.